New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
10:01 EDTMLNX, PFE, VCLK, OPTR, FIO, SYRG, RBCN, FLY, ABBV, VRTX, TRLA, DLA, GOOGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Delta Apparel (DLA) initiated with a Buy at Roth Capital... Fly Leasing (FLY) initiated with a Buy at Deutsche Bank... Google (GOOG) initiated with a Neutral at Sterne Agee... Optimer (OPTR) initiated with an Outperform at RW Baird... Trulia (TRLA) initiated with a Neutral at Goldman... ValueClick (VCLK) initiated with a Buy at Goldman... Vertex (VRTX) initiated with an Outperform at RW Baird... Rubicon (RBCN) coverage resumed with an Underweight at Piper Jaffray... Synergy Resources (SYRG) initiated with a Buy at Canaccord... Pfizer (PFE) reinstated with a Neutral at Credit Suisse... AbbVie (ABBV) initiated with a Neutral at Credit Suisse... Fusion-io (FIO) initiated with a Neutral at Janney Capital... Mellanox (MLNX) initiated with a Buy at Janney Capital.
News For GOOG;DLA;FLY;OPTR;TRLA;RBCN;VCLK;VRTX;SYRG;PFE;ABBV;FIO;MLNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>
January 29, 2016
07:54 EDTABBVAbbVie backs FY16 adjusted EPS $4.90-$5.10, consensus $5.03
Subscribe for More Information
07:54 EDTABBVAbbVie reports Q4 adjusted net revenue $6.36B, consensus $6.39B
Global HUMIRA sales increased 16% on an operational basis to $3.72B, excluding the impact of foreign exchange. Exceptional U.S. HUMIRA growth of 20.7% was driven by continued momentum across all three major market categories - rheumatology, dermatology and gastroenterology. International HUMIRA sales growth was also strong in the fourth quarter, up 9.7 percent on an operational basis. Reported international HUMIRA sales growth in the quarter was reduced by 13.1 percent due to unfavorable foreign exchange. Fourth-quarter global IMBRUVICA net revenue was $343 million, with U.S. sales of $295 million and international profit sharing of $48 million for the quarter.
07:52 EDTABBVAbbVie reports Q4 adjusted EPS $1.13, consensus $1.12
Reports Q4 revenue $6.40B, consensus $6.39B.
07:49 EDTABBVBristol-Myers, AbbVie receive 'positive' CHMP opinion for Empliciti
Subscribe for More Information
06:29 EDTGOOGOptions expected to be active: AMZN EA MSFT EWJ FLEX SWKS GOOG GOOGL FB
Subscribe for More Information
05:39 EDTPFEPfizer: LIS awards infliximab biosimilar tender to Inflectra, Reuters reports
Pfizer says that the Norwegian Drug Procurement Cooperation has awarded its product Inflectra an infliximab biosimilar tender, Reuters reports. Reference Link
January 28, 2016
19:09 EDTGOOGOn The Fly: After Hours Movers
UP AFTER EARNINGS: Gigamon (GIMO), up 15.2%... QLogic (QLGC), up 11%... Fortinet (FTNT), up 9.2%... ShoreTel (SHOR), up 5.7%... Skyworks (SWKS), up 3.6%... Flextronics (FLEX), up 4.6%... Microsoft (MSFT), up 3.6%... Proofpoint (PFPT), up 3.1%. ALSO HIGHER: Palo Alto Networks (PANW) is up 1.1% and FireEye (FEYE) is up 1.6% after Fortinet reported quarterly results. DOWN AFTER EARNINGS: Amazon.com (AMZN), down 13.2%... Synaptics (SYNA), down 3.8%... Electronic Arts (EA), down 8%... Quality Systems (QSII), down 9%... Visa (V), down 1.2%. ALSO LOWER: Facebook (FB) is down 1.2%, Netflix (NFLX) is down 2.7%, and Alphabet (GOOG, GOOGL) is down 1.5% and 1.7%, respectively, after Amazon reported quarterly results.
15:05 EDTGOOGEarnings Watch: Analysts more bullish on Microsoft since last quarter's blowout
Microsoft (MSFT) is scheduled to report results of its second quarter of fiscal year 2016 after the market close on Thursday, January 28, with a conference call scheduled for 5:30 pm ET. Microsoft, a member of the Dow Jones Industrial Average, sells and licenses software to consumers and businesses, offers cloud computing and other business services, and markets computer, phone and gaming hardware. EXPECTATIONS: Analysts are looking for earnings per share of 71c on revenue of $25.26B, according to First Call. The consensus range for EPS is 66c-75c on revenue of $24.62B-$25.92B. On its last earnings conference call, Microsoft said it expected Q2 productivity revenue of $6.6B-$6.67B, Q2 revenue for intelligent cloud of $6.2B-$6.3B and Q2 personal computing revenue of $12B-$12.4B. LAST QUARTER: On October 22, Microsoft reported first quarter earnings per share of 67c, beating the consensus analyst forecast of 59c. The company's revenue came in at $21.7B, topping the consensus estimate of $21.03B. NEWS: On December 17, Microsoft announced a new joint venture that will license, deploy, manage and optimize Windows 10 for China's government agencies and certain state owned enterprises and provide ongoing support and services for these customers. That announcement followed Microsoft inking a partnership with Baidu (BIDU) to make it easy for their customers to upgrade to Windows 10 while providing local browsing and search experiences, and universal apps. On January 4, Microsoft said in a blog post that operating system Windows 10 was currently active on over 200M devices, bringing the company closer to its goal of seeing Windows 10 active on more than 1B devices. STREET RESEARCH: On the day after the company's last earnings report, BofA Merrill Lynch analyst Kash Rangan upgraded Microsoft to Buy from Neutral, saying he believes the company was at a turning point with its operating income headed for growth following four years of flattish performance. At the time, Rangan increased his price target on the stock to $63 from $46. On November 20, Deutsche Bank analyst Ross Sandler wrote in a note to investors that actions taken by Google parent Alphabet (GOOG) and comments made by its executives indicated that the tech giant plans to make a major push in the cloud infrastructure market. Based on a comment from executive Urs Holzle that the company's revenue from the cloud could surpass its ad revenue by 2020, Sandler estimated that the company is seeking to boost its cloud revenue to $100B by 2020. Google's push in the cloud is negative for Microsoft, but it will take years for Google to build up its cloud business to the point where it's competitive with Microsoft's cloud offering, Azure, the analyst contended. On November 30, Raymond James analyst Michael Turits upgraded Microsoft two notches to Strong Buy from Hold, predicting that the tech giant will become one of the few large scale cloud vendors that can succeed across the industry's three main segments. Microsoft will emerge alongside Amazon (AMZN) and Google as part of a small group of "hyperscale" cloud vendors that can combine Infrastructure-as-a-Service, Platform-as-a-Service and Software-as-a-Service, predicted Turits. Forecasting that Microsoft's cloud revenue will grow at a compound annual growth rate of 6% between fiscal 2016 and fiscal 2018, the analyst estimated that the company's overall profit growth would accelerate to at least 8% over the long-term. Moreover, the growth of Microsoft's Office business appears to be accelerating, despite competition from Google, said Turits, who set a $62 price target on the shares. On January 13, Morgan Stanley analyst Keith Weiss upgraded Microsoft to Overweight, the firm's equivalent of a "Buy" rating, from Equal Weight. Microsoft is emerging as a public cloud winner, is gaining share in the data center market and Office 365 is seeing its base grow and its per user pricing increase, all of which set up the company to resume earnings growth after a five year period of stagnation, Weiss told investors. The analyst, who believes Microsoft's earnings growth and "aggressive" return of capital to shareholders should help its multiple expand, raised his price target on the stock to $66 from $57. This morning, UBS analyst Brent Thill said that given Apple's (AAPL) recent negative commentary around macro uncertainty he was lowering his second half of the year estimates for Microsoft on the potential for more conservative guidance when it issues its Q2 report after the closing bell. Thill trimmed his price target on Microsoft to $58 from $60, but said he remains confident the company is making the right moves to the cloud and kept a Buy rating on shares. PRICE ACTION: On the day after the company's last quarterly report, Microsoft shares jumped 10.4% to $53.03. In late afternoon trading ahead of Thursday's report, Microsoft advanced 1.25% to $51.86.
14:29 EDTABBVNotable companies reporting before tomorrow's open
Subscribe for More Information
13:05 EDTABBVAbbVie volatility elevated into Q4 and outlook
Subscribe for More Information
09:19 EDTMLNXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Facebook (FB), up 13.9%... Under Armour (UA), up 14.6%... MicroStrategy (MSTR), up 8.9%... Harley-Davidson (HOG), up 8%... Paypal (PYPL), up 6%... Mellanox (MLNX), up 7.9%... Cirrus Logic (CRUS), up 6.2%... Alibaba (BABA), up 4.5%. ALSO HIGHER: Neos Therapeutics (NEOS), up 61.4% after the FDA approved Adzenys XR-ODT for the treatment of ADHD... Exelixis (EXEL), up 4.7% after the U.S. FDA determined the company's New Drug Application for cabozantinib is sufficiently complete... Kinder Morgan (KMI), up 6.7% after being upgraded at Credit Suisse and Stifel. DOWN AFTER EARNINGS: OSI Systems (OSIS), down 21.3%... ServiceNow (NOW), down 22.3%... eBay (EBAY), down 11.5%... InvenSense (INVN), down 10.5%... Juniper Networks (JNPR), down 9.3%... Hologic (HOLX), down 4.4%... Abbott Laboratories (ABT), down 3.6%... Potash (POT), down 2.1%... Qualcomm (QCOM), down 3.6%.
08:04 EDTGOOGHarman CEO: On track to deliver full year plan
"I am pleased to announce our 11th consecutive quarter of top and bottom line growth. Our strong first half results were in-line with our expectations. While we are closely monitoring macroeconomic developments, at this time, we are on track to deliver on our full year plan," said Dinesh C. Paliwal, Harman (HAR) Chairman, President and CEO. "HARMAN continues to innovate and bring industry-first solutions to market. We are also partnering with key technology leaders such as Google (GOOG), Microsoft (MSFT) and Under Armour (UA) to capitalize on the opportunities presented by IoT for automotive, enterprise and consumer electronics. In addition, our acquisition of TowerSec will strengthen our cybersecurity leadership position for automotive."
07:45 EDTGOOGFacebook price target raised to $140 from $125 at Cowen
Subscribe for More Information
07:12 EDTABBVAbbVie intiates enrollment in Phase 3 clinical program for Elagolix
AbbVie (ABBV), in cooperation with Neurocrine Biosciences (NBIX), announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. These studies are designed to assess the change in menstrual blood loss utilizing the alkaline hematin method, comparing baseline to month six of treatment. Additional secondary efficacy endpoints are being evaluated; including assessing changes in fibroid volume, monthly blood loss and hemoglobin levels. Bone mineral density will also be assessed.
06:24 EDTGOOGSNP calls on EU to probe Google's U.K. tax agreement, FT reports
Subscribe for More Information
06:22 EDTGOOGGoogle, Apple push back on Euro tax deals, FT reports
Subscribe for More Information
06:19 EDTGOOGItaly finance police say Google avoided EUR227M in taxes, Reuters says
Subscribe for More Information
05:59 EDTVRTXVertex price target lowered to $143 from $180 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Vertex Pharmaceuticals to $143 to reflect reduced cystic fibrosis sales assumptions following the company's Q4 results. The analyst says there is "no surprises" in Vertex's quarter and keeps an Overweight rating on the name.
05:54 EDTABBVStocks with implied volatility movement; EMR ABBV
Stocks with implied volatility movement; Emerson (EMR) 38, AbbVie (ABBV) 42 according to iVolatility.
05:37 EDTABBVAbbVie announces venetoclax granted Breakthrough Therapy Designation by FDA
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use